2013 Form 10-K Financial Statement

#000114420414012919 Filed on March 03, 2014

View on sec.gov

Income Statement

Concept 2013 2012 Q4 2012 Q3
Revenue $123.0K $0.00 $0.00
YoY Change
Cost Of Revenue $190.0K
YoY Change
Gross Profit -$67.00K
YoY Change
Gross Profit Margin -54.47%
Selling, General & Admin $8.926M $1.850M $1.453M
YoY Change 48.45% 74.53% 22.62%
% of Gross Profit
Research & Development $4.923M $1.210M $696.0K
YoY Change 32.13% 53.16% -27.65%
% of Gross Profit
Depreciation & Amortization $130.0K $30.00K $40.00K
YoY Change 0.0% 0.0% 33.33%
% of Gross Profit
Operating Expenses $13.85M $3.057M $2.149M
YoY Change 42.2% 65.24% 0.09%
Operating Profit -$14.09M -$3.057M -$2.149M
YoY Change 44.68% 0.09%
Interest Expense $9.000K $80.00K
YoY Change 700.0%
% of Operating Profit
Other Income/Expense, Net $189.0K -$40.00K $9.000K
YoY Change 166.2% 50.0%
Pretax Income -$13.90M -$3.020M -$2.140M
YoY Change 43.78% 64.13% -0.05%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$13.90M -$3.016M -$2.140M
YoY Change 43.78% 82.79% -0.05%
Net Earnings / Revenue -11301.63%
Basic Earnings Per Share -$0.29 -$0.06 -$0.04
Diluted Earnings Per Share -$0.29 -$0.06 -$0.04
COMMON SHARES
Basic Shares Outstanding 47.76M shares 45.86M shares 47.52M shares
Diluted Shares Outstanding 47.76M shares 47.52M shares

Balance Sheet

Concept 2013 2012 Q4 2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.07M $27.42M $29.32M
YoY Change -4.92% -23.17% -22.15%
Cash & Equivalents $12.34M $7.476M $29.32M
Short-Term Investments $13.73M $19.95M
Other Short-Term Assets $820.0K $270.0K $360.0K
YoY Change 164.52% -6.9% -16.28%
Inventory $250.0K $220.0K
Prepaid Expenses
Receivables $190.0K $10.00K
Other Receivables $120.0K $70.00K
Total Short-Term Assets $27.45M $27.99M $29.84M
YoY Change -1.93% -22.52% -21.66%
LONG-TERM ASSETS
Property, Plant & Equipment $940.0K $1.052M $1.076M
YoY Change -10.48% 0.77% 7.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $240.0K $10.00K
YoY Change 2300.0%
Total Long-Term Assets $1.180M $1.068M $1.076M
YoY Change 11.32% 2.3% 7.6%
TOTAL ASSETS
Total Short-Term Assets $27.45M $27.99M $29.84M
Total Long-Term Assets $1.180M $1.068M $1.076M
Total Assets $28.63M $29.06M $30.91M
YoY Change -1.45% -21.83% -20.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $270.0K $994.0K $228.0K
YoY Change -72.73% 1775.47% 356.0%
Accrued Expenses $540.0K $413.0K $459.0K
YoY Change 31.71% -13.42% -52.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.110M $1.424M $687.0K
YoY Change -21.83% 168.68% -38.66%
LONG-TERM LIABILITIES
Long-Term Debt $9.600M $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $10.00K
YoY Change -100.0%
Total Long-Term Liabilities $9.600M $10.00K $0.00
YoY Change 95900.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.110M $1.424M $687.0K
Total Long-Term Liabilities $9.600M $10.00K $0.00
Total Liabilities $10.71M $1.429M $690.0K
YoY Change 654.23% 169.62% -38.39%
SHAREHOLDERS EQUITY
Retained Earnings -$335.2M -$332.2M
YoY Change 2.97%
Common Stock $362.9M $362.4M
YoY Change 0.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $17.92M $27.63M $30.23M
YoY Change
Total Liabilities & Shareholders Equity $28.63M $29.06M $30.91M
YoY Change -1.45% -21.83% -20.92%

Cashflow Statement

Concept 2013 2012 Q4 2012 Q3
OPERATING ACTIVITIES
Net Income -$13.90M -$3.016M -$2.140M
YoY Change 43.78% 82.79% -0.05%
Depreciation, Depletion And Amortization $130.0K $30.00K $40.00K
YoY Change 0.0% 0.0% 33.33%
Cash From Operating Activities -$13.68M -$1.840M -$1.820M
YoY Change 94.34% -2.65% -1.09%
INVESTING ACTIVITIES
Capital Expenditures $23.00K -$20.00K -$20.00K
YoY Change -84.35% -75.0%
Acquisitions
YoY Change
Other Investing Activities $6.280M -$19.99M
YoY Change -131.42%
Cash From Investing Activities $6.253M -$20.00M -$20.00K
YoY Change -131.06% 24900.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $12.29M 0.000 0.000
YoY Change -1283.91% -100.0%
NET CHANGE
Cash From Operating Activities -$13.68M -1.840M -1.820M
Cash From Investing Activities $6.253M -20.00M -20.00K
Cash From Financing Activities $12.29M 0.000 0.000
Net Change In Cash $4.864M -21.84M -1.840M
YoY Change -117.24% 1003.03% 0.0%
FREE CASH FLOW
Cash From Operating Activities -$13.68M -$1.840M -$1.820M
Capital Expenditures $23.00K -$20.00K -$20.00K
Free Cash Flow -$13.70M -$1.820M -$1.800M
YoY Change 90.69% 0.55% -2.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011 acur Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
0 USD
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 USD
CY2012 acur Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
0 USD
CY2013 acur Provision To Reduce Inventory To Net Realizable Value
ProvisionToReduceInventoryToNetRealizableValue
250000 USD
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
194000 USD
CY2011 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
0 USD
CY2012 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
0 USD
CY2013 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
84000 USD
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
219000 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
282000 USD
CY2011 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
141000 USD
CY2012 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-110000 USD
CY2013 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-43000 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
33000 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
16000 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
358000 USD
CY2013 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
186000 USD
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 USD
CY2011 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
CY2012 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-6000 USD
CY2012 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
20306000 USD
CY2013 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
7611000 USD
CY2011 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 USD
CY2012 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
320000 USD
CY2013 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
13887000 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
131000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
147000 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
23000 USD
CY2011 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-209000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20133000 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6253000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-131000 USD
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-64000 USD
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-720000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12312000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7038000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
53000 USD
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
941000 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13678000 USD
CY2011 us-gaap Interest Paid
InterestPaid
26000 USD
CY2012 us-gaap Interest Paid
InterestPaid
0 USD
CY2013 us-gaap Interest Paid
InterestPaid
0 USD
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
-284000 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
108000 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
42000 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11640000 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-28209000 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4864000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24045000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35685000 USD
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
217000 USD
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9000 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9000 USD
CY2011 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
5000 USD
CY2012 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
1000 USD
CY2013 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
1000 USD
CY2011 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1839000 USD
CY2012 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1048000 USD
CY2013 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
716000 USD
CY2011 acur Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
0 USD
CY2012 acur Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
0 USD
CY2013 acur Proceeds From Market Offering Of Shares
ProceedsFromMarketOfferingOfShares
-3328000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-541000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1038000 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12289000 USD
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Concentration of Credit Risk</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt"> </font>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt">We invest our excess cash in accordance with the investment policy</font> <font style="FONT-SIZE: 10pt">approved by our Board of Directors</font> <font style="COLOR: black; FONT-SIZE: 10pt"> that seeks a combination of both liquidity and safety of principal, such as investments in instruments issued by the United States government and investment grade corporate bonds.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt">Our accounts receivable arise from our product sales of Nexafed&#174; and represents amounts due from wholesalers in the health care and pharmaceuticals industries and from chain drug stores. The Company has performed a credit evaluation of its customers and may maintain an allowance for potentially uncollectable accounts. We have not experienced any losses on uncollectable accounts.</font></div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt"> </font>&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Sales to certain of our customers accounted for 10% or more of our annual net revenues, whether recognized or deferred, during 2013 as illustrated below: <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:center; TEXT-INDENT: 0in; WIDTH: 100%" align="center"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0px:auto; WIDTH: 50%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="center"> <tr style="HEIGHT: 12px"> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Customer</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="36%"> <div>Rite Aid Corporation</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="12%"> <div>52</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Cardinal Health, Inc.</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="12%"> <div>15</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Trading Symbol
TradingSymbol
ACUR
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48847737 shares
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2013Q2 dei Entity Public Float
EntityPublicFloat
36000000 USD
CY2011 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
20000000 USD
CY2012 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
0 USD
CY2013 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
0 USD
CY2011 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
34000 USD
CY2012 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
8000 USD
CY2013 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
0 USD
CY2012Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
0 USD
CY2013Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
231000 USD
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
0 USD
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
9600000 USD
CY2011 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-8000 USD
CY2012 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-8000 USD
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 USD
CY2011 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-126000 USD
CY2012 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
0 USD
CY2013 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
0 USD
CY2011 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
0 USD
CY2012 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-6000 USD
CY2013 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
12000 USD
CY2011 acur Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
1076000 USD
CY2013 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
46800000 USD
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
137600000 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
300000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
100000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
13000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2700000 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
28000 USD
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <strong><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="COLOR: black; FONT-SIZE: 10pt"> Management is required to make certain estimates and assumptions in order to prepare consolidated financial statements in conformity with GAAP. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes.</font> <font style="FONT-SIZE: 10pt">Actual results could differ from those estimates. Management periodically evaluates estimates used in the preparation of the consolidated financial statements for continued reasonableness. Appropriate adjustments, if any, to the estimates used are made prospectively based on such periodic evaluations.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013 acur Increase Decrease In Deferred Program Fee Revenue
IncreaseDecreaseInDeferredProgramFeeRevenue
0 USD
CY2011 acur Proceeds From Issuance Of Common Stock Value Under Market Offerings
ProceedsFromIssuanceOfCommonStockValueUnderMarketOfferings
0 USD
CY2012 acur Proceeds From Issuance Of Common Stock Value Under Market Offerings
ProceedsFromIssuanceOfCommonStockValueUnderMarketOfferings
0 USD
CY2013 acur Proceeds From Issuance Of Common Stock Value Under Market Offerings
ProceedsFromIssuanceOfCommonStockValueUnderMarketOfferings
102000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
400000 USD
CY2012Q4 us-gaap Inventory Gross
InventoryGross
200000 USD
CY2013Q4 us-gaap Inventory Gross
InventoryGross
500000 USD
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
10000000 USD
CY2013Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0835 pure
CY2013 acur Payment Of Royalty Maximum Contractual Term
PaymentOfRoyaltyMaximumContractualTerm
P45D
CY2012Q1 us-gaap Revenues
Revenues
0 USD
CY2013Q1 us-gaap Revenues
Revenues
4000 USD
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1100000 USD
CY2012Q2 us-gaap Revenues
Revenues
0 USD
CY2013Q4 acur Debt Default Long Term Debt Percentage
DebtDefaultLongTermDebtPercentage
0.1335 pure
CY2013Q2 us-gaap Revenues
Revenues
1000 USD
CY2012Q3 us-gaap Revenues
Revenues
0 USD
CY2013Q3 us-gaap Revenues
Revenues
83000 USD
CY2012Q4 us-gaap Revenues
Revenues
0 USD
CY2011 acur Share Based Compensation Share Based Payment Awards Cashless Exercises
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercises
935000 shares
CY2012 acur Share Based Compensation Share Based Payment Awards Cashless Exercises
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercises
24000 shares
CY2013Q4 us-gaap Revenues
Revenues
35000 USD
CY2013 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2018-12-01
CY2012Q1 us-gaap Operating Expenses
OperatingExpenses
2344000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
3308000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
4248000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
2189000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
3141000 USD
CY2012Q3 us-gaap Operating Expenses
OperatingExpenses
2149000 USD
CY2012Q4 us-gaap Operating Expenses
OperatingExpenses
3057000 USD
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
3516000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2344000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4244000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2189000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3140000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2149000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3225000 USD
CY2013 acur Debt Instrument Amortization Date
DebtInstrumentAmortizationDate
2015-04-01
CY2013 acur Share Based Compensation Share Based Payment Awards Cashless Exercises
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercises
24000 shares
CY2011 acur Taxes Withheld On Issuance Of Stock Based Awards
TaxesWithheldOnIssuanceOfStockBasedAwards
1300000 USD
CY2012 acur Taxes Withheld On Issuance Of Stock Based Awards
TaxesWithheldOnIssuanceOfStockBasedAwards
31 USD
CY2013 acur Taxes Withheld On Issuance Of Stock Based Awards
TaxesWithheldOnIssuanceOfStockBasedAwards
32 USD
CY2011 acur Statutory Minimum Payroll Taxes
StatutoryMinimumPayrollTaxes
886 USD
CY2012 acur Statutory Minimum Payroll Taxes
StatutoryMinimumPayrollTaxes
15 USD
CY2013 acur Statutory Minimum Payroll Taxes
StatutoryMinimumPayrollTaxes
4 USD
CY2011 acur Number Of Shares Issued On Cashless Exercises
NumberOfSharesIssuedOnCashlessExercises
383000 shares
CY2012 acur Number Of Shares Issued On Cashless Exercises
NumberOfSharesIssuedOnCashlessExercises
9000 shares
CY2013 acur Number Of Shares Issued On Cashless Exercises
NumberOfSharesIssuedOnCashlessExercises
6000 shares
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3057000 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3481000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-2333000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-4218000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-2179000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-3076000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-2140000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-3190000 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-3016000 USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-3417000 USD
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2012 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2013 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2011 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
136000 shares
CY2012 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2013 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
300000 USD
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2012Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2013Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2013 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
200000 USD
CY2013 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
830000 shares
CY2013Q4 us-gaap Inventory Net
InventoryNet
250000 USD
CY2013 acur Proceeds From Non Refundable Upfront Fees For Research And Development Arrangment Contract To Perform For Other
ProceedsFromNonRefundableUpfrontFeesForResearchAndDevelopmentArrangmentContractToPerformForOther
30000000 USD
CY2011 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
500000 USD
CY2013 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
300000 USD
CY2013 us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
30000000 USD
CY2008Q2 us-gaap Proceeds From License Fees Received
ProceedsFromLicenseFeesReceived
3000000 USD
CY2011Q2 acur Proceedds From Research And Development Contingent Consideration Payment
ProceeddsFromResearchAndDevelopmentContingentConsiderationPayment
20000000 USD
CY2013 us-gaap Proceeds From Collaborators
ProceedsFromCollaborators
78500000 USD
CY2011 us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
100000 USD
CY2012 us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
100000 USD
CY2013 us-gaap Utilities Operating Expense Depreciation And Amortization
UtilitiesOperatingExpenseDepreciationAndAmortization
100000 USD
CY2011 acur Share Based Compensation Share Based Payment Awards Cashless Exercises Withheld Minimum Payroll Taxes
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercisesWithheldMinimumPayrollTaxes
324000 shares
CY2013Q4 acur Restricted Stock Units Sale Price
RestrictedStockUnitsSalePrice
0.01
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2012Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
CY2013Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2012 acur Share Based Compensation Share Based Payment Awards Cashless Exercises Withheld Minimum Payroll Taxes
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercisesWithheldMinimumPayrollTaxes
10000 shares
CY2011 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
366000 shares
CY2013 acur Share Based Compensation Share Based Payment Awards Cashless Exercises Withheld Minimum Payroll Taxes
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercisesWithheldMinimumPayrollTaxes
17000 shares
CY2011 acur Share Based Compensation Share Based Payment Awards Cashless Exercises Withheld Statutory Minimum Payroll Taxes
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercisesWithheldStatutoryMinimumPayrollTaxes
228000 shares
CY2012 acur Share Based Compensation Share Based Payment Awards Cashless Exercises Withheld Statutory Minimum Payroll Taxes
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercisesWithheldStatutoryMinimumPayrollTaxes
5000 shares
CY2013 acur Share Based Compensation Share Based Payment Awards Cashless Exercises Withheld Statutory Minimum Payroll Taxes
ShareBasedCompensationShareBasedPaymentAwardsCashlessExercisesWithheldStatutoryMinimumPayrollTaxes
1000 shares
CY2012 acur Increase Decrease In Deferred Program Fee Revenue
IncreaseDecreaseInDeferredProgramFeeRevenue
0 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7476000 USD
CY2012Q4 us-gaap Marketable Securities
MarketableSecurities
19946000 USD
CY2012Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
5000 USD
CY2012Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
36000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
219000 USD
CY2012Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
43000 USD
CY2013Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross Current
DeferredTaxAssetsGrossCurrent
186000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
941000 USD
CY2012Q4 us-gaap Other Assets
OtherAssets
11000 USD
CY2012Q4 us-gaap Assets
Assets
29059000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
994000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1424000 USD
CY2011 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
32000 USD
CY2012 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
79000 USD
CY2013 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
194000 USD
CY2011 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0 USD
CY2012 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0 USD
CY2013 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
4000 USD
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2000 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
71000 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
189000 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
10532000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9668000 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-13901000 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
147000 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
27630000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
629000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1429000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-9668000 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
10385000 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-13901000 USD
CY2011 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
0 USD
CY2012 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
-40000 USD
CY2013 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
59000 USD
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-40000 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
59000 USD
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10385000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9708000 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13842000 USD
CY2011 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
483000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
362422000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
366533000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-335211000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-349112000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-40000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
17923000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29059000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28630000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
459000 USD
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
27453000 USD
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2011 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
CY2011 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47505000 shares
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47521000 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47764000 shares
CY2011 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48007000 shares
CY2012 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47521000 shares
CY2013 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47764000 shares
CY2013Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13000000 USD
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1900000 shares
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2200000 shares
CY2012Q4 acur Exercise Price Of Warrants
ExercisePriceOfWarrants
3.40
CY2013Q4 acur Exercise Price Of Warrants
ExercisePriceOfWarrants
3.15
CY2012Q4 acur Class Of Warrant Or Right Expiration Date
ClassOfWarrantOrRightExpirationDate
August 2014
CY2013Q4 acur Class Of Warrant Or Right Expiration Date
ClassOfWarrantOrRightExpirationDate
December 2020
CY2011 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
45016000 shares
CY2012 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
45863000 shares
CY2013 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
46935000 shares
CY2011 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
2489000 shares
CY2012 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
1658000 shares
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2805000 shares
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5152000 shares
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
413000 USD
CY2012Q4 us-gaap Deferred Revenue
DeferredRevenue
5000 USD
CY2013Q4 us-gaap Deferred Revenue
DeferredRevenue
287000 USD
CY2012Q4 us-gaap Other Liabilities
OtherLiabilities
5000 USD
CY2013Q4 us-gaap Other Liabilities
OtherLiabilities
0 USD
CY2013Q4 us-gaap Liabilities
Liabilities
10707000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
19000 USD
CY2013 acur Percentage Of Royalty
PercentageOfRoyalty
0.05 pure
CY2013 acur Percentage Of Royalty Deduct To Settle Third Party Claim
PercentageOfRoyaltyDeductToSettleThirdPartyClaim
0.5 pure
CY2013 acur Percentage Of Royalty Of Royalty Payable Minimum
PercentageOfRoyaltyOfRoyaltyPayableMinimum
0.8 pure
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1200000 USD
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
3100000 USD
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
6300000 USD
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
6800000 USD
CY2012Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
19900000 USD
CY2013Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
13700000 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
20000000 USD
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
13700000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.14 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.14 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.11 pure
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.39
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.60
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.54
CY2011 us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
CY2012 us-gaap Royalty Revenue
RoyaltyRevenue
0 USD
CY2013 us-gaap Royalty Revenue
RoyaltyRevenue
10000 USD
CY2012 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
0 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
0 USD
CY2012 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
100000 USD
CY2013 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
0 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
55000 USD
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
78000 USD
CY2012Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
216000 USD
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
293000 USD
CY2012Q4 acur Other Accrued Taxes Current
OtherAccruedTaxesCurrent
5000 USD
CY2013Q4 acur Other Accrued Taxes Current
OtherAccruedTaxesCurrent
1000 USD
CY2012Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
20000 USD
CY2013Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
15000 USD
CY2012Q4 acur Manufacturing Services Costs
ManufacturingServicesCosts
21000 USD
CY2013Q4 acur Manufacturing Services Costs
ManufacturingServicesCosts
14000 USD
CY2012Q4 acur Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
21000 USD
CY2013Q4 acur Accrued Other Professional Fees Current
AccruedOtherProfessionalFeesCurrent
0 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
75000 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
140000 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
2458000 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
1733000 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
1215000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0 pure
CY2011 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
0 USD
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
0 USD
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
113000 USD
CY2011 us-gaap Revenues
Revenues
20466000 USD
CY2012 us-gaap Revenues
Revenues
0 USD
CY2013 us-gaap Revenues
Revenues
123000 USD
CY2011 acur Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
0 USD
CY2012 acur Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
0 USD
CY2013 acur Cost Of Sales Excluding Inventory Write Down
CostOfSalesExcludingInventoryWriteDown
114000 USD
CY2011 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2012 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2013 us-gaap Inventory Write Down
InventoryWriteDown
250000 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4037000 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3726000 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4923000 USD
CY2011 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5895000 USD
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6013000 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8926000 USD
CY2013 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
829000 shares
CY2013 us-gaap Costs And Expenses
CostsAndExpenses
14213000 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
217000 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
24341000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2458000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1733000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1215000 USD
CY2011 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2012 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 USD
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 USD
CY2013 acur Issuance Of Common Stock Value Under Market Offerings
IssuanceOfCommonStockValueUnderMarketOfferings
3226000 USD
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5892000 shares
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
36643000 USD
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
131000 USD
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
131000 USD
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
134000 USD
CY2012 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
0 USD
CY2013 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-238000 USD
CY2011 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
-77000 USD
CY2012 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
0 USD
CY2013 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
-185000 USD
CY2011 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
626000 USD
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
473000 USD
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
369000 USD
CY2011 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-55000 USD
CY2012 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
2000 USD
CY2013 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
2000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1758000 USD
CY2011 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3863000 USD
CY2012 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2812000 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
4742000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2597000 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2617000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1545000 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1676000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2522000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
2741000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
2979000 USD
CY2013Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
0 USD
CY2013Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10000000 USD
CY2013Q4 us-gaap Secured Debt
SecuredDebt
10000000 USD
CY2013 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
298000 shares
CY2013Q4 us-gaap Share Price
SharePrice
1.595
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
26674000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
548000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
-443000 shares
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
46830000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
4434000 USD
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
2843000 USD
CY2012Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
887000 USD
CY2013Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
1433000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3486000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
-15000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.77
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.54
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2261000 USD
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-20000 USD
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
119000 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.75
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.17
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.71
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
623000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.019 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.017 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.019 pure
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.034 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.020 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.029 pure
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
533000 shares
CY2011 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3510000 USD
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3287000 USD
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4690000 USD
CY2011 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
6000 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
35461000 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
53486000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
35461000 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
53486000 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2011 acur Program Fee Revenue
ProgramFeeRevenue
466000 USD
CY2012 acur Program Fee Revenue
ProgramFeeRevenue
0 USD
CY2013 acur Program Fee Revenue
ProgramFeeRevenue
0 USD
CY2011 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 USD
CY2012 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 USD
CY2013 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
9000 USD
CY2011 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1076000 USD
CY2012 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2013 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
-231000 USD
CY2013 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2011 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 USD
CY2012 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 USD
CY2013 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
10000000 USD
CY2011 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2012 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2011 acur Increase Decrease In Deferred Program Fee Revenue
IncreaseDecreaseInDeferredProgramFeeRevenue
466000 USD
CY2013 acur Debt Instrument Deferment Of Amortization Date Description
DebtInstrumentDefermentOfAmortizationDateDescription
The Amortization Date is April 1, 2015, but shall automatically become April 1, 2016 if the Company achieves 75% of its projected Nexafed cash receipts and 75% of its projected Oxecta cash receipts for the fiscal year ending December 31, 2014 (collectively, the First Revenue Event).
CY2013 acur Debt Instrument Further Deferment Of Amortization Date Description
DebtInstrumentFurtherDefermentOfAmortizationDateDescription
The Amortization Date will be further deferred until April 1, 2017 if the First Revenue Event occurs and in addition the Company achieves 75% of its projected Nexafed cash receipts and 75% of its projected Oxecta cash receipts for the fiscal year ending December 31, 2015 (collectively, the Second Revenue Event).
CY2013Q4 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
50000 USD
CY2013 acur Debt Consulting Placement Fee
DebtConsultingPlacementFee
100000 USD
CY2013 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
231000 USD
CY2013 acur Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
298000 shares
CY2013Q4 acur Warrants Exercise Price
WarrantsExercisePrice
1.595
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
400000 USD
CY2013 acur Warrants Expiry Date
WarrantsExpiryDate
2020-12-27
CY2012Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
400000 USD
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
10000000 USD
CY2013Q4 acur Research And Development Arrangement Contract To Perform For Others Expenses Receivable
ResearchAndDevelopmentArrangementContractToPerformForOthersExpensesReceivable
360000 USD
CY2011 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2800000 USD
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2800000 USD
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
18000000 USD
CY2013 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
2800000 USD

Files In Submission

Name View Source Status
0001144204-14-012919-index-headers.html Edgar Link pending
0001144204-14-012919-index.html Edgar Link pending
0001144204-14-012919.txt Edgar Link pending
0001144204-14-012919-xbrl.zip Edgar Link pending
acur-20131231.xml Edgar Link completed
acur-20131231.xsd Edgar Link pending
acur-20131231_cal.xml Edgar Link unprocessable
acur-20131231_def.xml Edgar Link unprocessable
acur-20131231_lab.xml Edgar Link unprocessable
acur-20131231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ft0001img-1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v367838_10k.htm Edgar Link pending
v367838_ex10-24.htm Edgar Link pending
v367838_ex10-6.htm Edgar Link pending
v367838_ex10-7.htm Edgar Link pending
v367838_ex10-8.htm Edgar Link pending
v367838_ex23-1.htm Edgar Link pending
v367838_ex31-1.htm Edgar Link pending
v367838_ex31-2.htm Edgar Link pending
v367838_ex32.htm Edgar Link pending